bd max system covid

The test will be run on the BD MAX System, a molecular diagnostic platform already in use at hundreds of laboratories in nearly every state across the country. © 2020 BD. About BD BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner. Learn more about BD Synapsys. FRANKLIN LAKES, N.J. and BIRMINGHAM, Ala., March 16, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and BioGX Inc, a molecular diagnostics company, today announced that the companies have submitted Emergency Use Authorization requests to the U.S. Food and Drug Administration (FDA) for new diagnostic tests that, if authorized, would increase the potential capacity to screen for COVID-19 (coronavirus) by thousands of tests per day. BioGX SARS-CoV-2 Reagents for BD MAX System: Results in Table 2A: Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Wantai SARS-CoV-2 RT-PCR Kit : … Two studies were completed to determine clinical performance. Each BD MAX™ System can process 24 samples simultaneously. "The foundation of BioGX firmly stands on its team's ability to step up and address such unmet needs with speed. The Emergency Use Authorization authority allows FDA to help strengthen the nation's public health protections against chemical, biological, radiological and nuclear threats by facilitating the availability and use of medical countermeasures needed during public health emergencies. It has not been authorized for use to detect any other viruses or pathogens. 0 results found for "[term]". BD Synapsys Informatics was among the first life science diagnostics informatics platforms to receive the Underwriters Laboratory Cybersecurity Assurance Program certification, an independent third-party evaluation that uses standardized, testable criteria for assessing software vulnerabilities and weaknesses. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner. This empowers customers to focus on what matters most: Caring for their … The solution also offers configured reporting capabilities, which allow customers in the U.S. to generate reports in accordance with the U.S. Coronavirus Aid, Relief, and Economic Security (CARES) Act. The CARES Act requires COVID-19 testing facilities to report testing data to local and federal health authorities daily, including the number of tests performed, results and key patient demographics. In the first study, nasal specimens and either … ZARAGOZA, Spain and FRANKLIN LAKES, N.J., March 10, 2020 / PRNewswire / -- CerTest Biotec, along with BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the VIASURE SARS-CoV-2 Real Time PCR Detection Kit adapted for the BD MAX ™ System has been CE marked to the IVD Directive (98/79/CE). Both BD Veritor™ and BD MAX™ systems have been granted Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA) to perform SARS-CoV-2 diagnostic testing. BioGX B.V.’s 50+ molecular diagnostic products are marketed and sold in 100+ countries through its Global Distribution Network. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. About BD BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. "BD Synapsys™ Informatics unifies instrument-read COVID-19 test results from the BD Veritor™ and BD MAX™ systems," said Rajeev Sehgal, director of Informatics for BD Integrated Diagnostics Solutions. Antigen testing . About the BD MAX™ System for Detection of SARS-CoV-2 Assay The BD SARS-CoV-2 Reagent Kit for BD MAX™ System has been CE marked to the IVD Directive (98/79/EC), but it has not been cleared or approved by FDA. Each unit is capable of analyzing hundreds of samples per day. For more information on BD, please visit bd.com. BioGX, Inc., headquartered in Birmingham, Alabama, and its wholly owned subsidiary BioGX B.V., based in Amsterdam, The Netherlands, (collectively “BioGX”), develop and commercialize molecular diagnostics reagents across diverse applications. The Sample-ReadyTM technology is at the core of all product offerings for Clinical, Food Safety, Pharma and Water Quality molecular testing. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. The test will be run on the BD MAX™ System, a molecular diagnostic platform already in use at hundreds of laboratories in nearly every state across the country. For more information on BD, please visit bd.com. "The new CerTest kit will provide rapid COVID-19 diagnostic capabilities that can be run individually or combined with detection of Flu A, Flu B and RSV A and B," said Nelson Fernandes , managing director of CerTest Biotec. This kit allows BD MAX™ System users to run a single module that tests concurrently for COVID-19 and Influenza (Flu) and Respiratory Syncytial Virus (RSV). BD's (BDX) Real Time PCR Detection Kit enables BD MAX System users to run a single module that tests concurrently for COVID-19, flu and RSV. The system is fully automated, reducing the opportunity for human error and increasing the speed to result. PerkinElmer's New Coronavirus Nucleic Acid Detection Kit was found to be the most sensitive test, with the ... Dickinson's BioGX SARS CoV-2 test for the BD MAX system… The tests would help fill an urgent need across the U.S. for laboratories to access an easy-to-use, rapid diagnostic test to screen patients for COVID-19. The BioGX SARS-CoV-2 Reagents for BD MAX ™ System is a real-time RT-PCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in nasopharyngeal and oropharyngeal swab samples from individuals suspected of COVID-19 by their healthcare provider. "The solution's new encrypted reporting capabilities reduce the burden associated with manual reporting. BD Synapsys™ Informatics solution provides secure connectivity, integrated workflows, and on-demand actionable insights for laboratories and facilities with Clinical Laboratory Improvement Amendments (CLIA) waivers. All rights reserved. BD is closely monitoring the COVID-19 (coronavirus) situation across the world and guidance from the U.S. Centers for Disease Control and Prevention (CDC), the World Health Organization (WHO) and health officials in a variety of affected countries to protect the health and safety of BD employees while ensuring continued availability of our … The companies submitted the Emergency Use Authorization requests to FDA today. The BD MAX™ System is a fully-integrated, automated platform that performs nucleic acid extraction and real-time PCR providing results for up to 24 samples across multiple syndromes in less than three hours*. The company has supplied health care providers globally with millions of products used in of the fight against COVID-19, including swabs for flu and COVID-19 testing, rapid molecular diagnostic tests on the BD MAX™ System, 15-minute point-of-care antigen testing on the BD Veritor™ Plus System, infusion pumps, infusion sets and catheters. A nasopharyngeal specimen was collected and analysed for flu, RSV and SARS-CoV-2 on the BD MAX™ System. The test is … Each unit is capable of analyzing hundreds of samples per day. All rights reserved. The test helps fill an urgent need across the U.S. for hospitals to access an easy-to-use, rapid diagnostic test to screen patients and health care workers for COVID-19. This kit allows BD MAX™ System users to run a single module that tests concurrently for COVID-19 and Influenza (Flu) and Respiratory Syncytial Virus (RSV). FRANKLIN LAKES, N.J., Nov. 23, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced new reporting capabilities for COVID-19 data, enabling scheduled reports to be generated from BD Synapsys™ Informatics (version 3.84). About the BD Veritor™ System for Rapid Detection of SARS-CoV-2 Assay The BD Veritor™ Plus System for Rapid Detection of SARS-CoV-2 Assay has been CE marked to the IVD Directive (98/79/EC), but has not been cleared or approved by FDA. BD Statement on COVID-19 (Coronavirus) Updated November 2020. The BD SARS-CoV-2 Reagent Kit for BD MAX™ System has been CE marked to the IVD Directive (98/79/EC), but it has not been cleared or approved by FDA. The BD Synapsys™ solution's new capabilities allow global customers to create general-purpose reports with COVID-19 data from their BD Veritor™ and/or BD MAX™ systems… Each unit can return results in two to … Authorization to use our test would increase access across the U.S. to an automated, highly reliable SARS-CoV-2 test.". BioGX developed the assay for the BD MAX™ System in their Sample-Ready™ ready-to-use format to detect the presence of the SARS-CoV-2 virus, the cause of COVID-19. Used with the BD Veritor™ Plus System and/or the BD Max™ System, the BD Synapsys™ Informatics 3.84 solution allows customers to export all SARS-CoV-2 test results in a single daily report. Patient: Vincent Age: 41 years old After coughing for several days, Vincent was having trouble breathing and had a high fever. Please try new keyword. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BioGX operates in a cGMP compliant environment certified to International Standard ISO 13485. The company has supplied health care providers globally with millions of products used in of the fight against COVID-19, including swabs for flu and COVID-19 testing, rapid molecular diagnostic tests on the BD MAX™ System, 15-minute point-of-care antigen testing on the BD Veritor™ Plus System, infusion pumps, infusion sets and catheters. Testing is limited to U.S. laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 … COVID result: Positive. "Our BD MAX System is a versatile molecular platform that enables us to rapidly deliver molecular solutions across our laboratory customers and help communities in need during times of high anxiety." "For COVID-19 testing facilities – including labs, hospitals and nursing homes – the BD Synapsys™ Informatics solution's new reporting capabilities, supported by secure connectivity, simplifies the process of reporting test results to public health authorities.". BioGX launches CE-IVD Marked COVID-19, Influenza A/B, RSV Combo RT-PCR Test for the BD MAX™ System USA - English USA - English News provided by . "The new CerTest kit will provide rapid COVID-19 diagnostic capabilities that can be run individually or combined with detection of Flu A, Flu B and RSV A and B," said Nelson Fernandes , managing director of CerTest Biotec. The test is designed to detect viral nucleic acid from the virus that causes COVID-19 in upper respiratory specimens, such as nasal swabs. workers for COVID-19. The BD Veritor ™ System for Rapid Detection of SARS-CoV-2 is a chromatographic immunoassay for the direct and qualitative detection of SARS-CoV-2 antigens in nasal swabs from patients with signs and symptoms who are suspected of COVID-19. The test is authorized in the United States for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. The BD MAX ™ system offers you an efficient path to improved clinical outcomes by combining and automating extraction and thermocycling into a single platform capable of running both FDA-cleared and open system assays. The assay is based on the same viral RNA targeting sequences and real-time PCR detection method as the test developed by the U.S. Centers for Disease Control and Prevention (CDC). The BD Veritor™ Plus System is the portable, easy-to-use testing system that delivers reliable results in just minutes. This kit enables BD MAX System users to run a single module that tests for COVID-19 and Influenza (Flu), along with Respiratory Syncytial Virus (“RSV”) at once. "The solution's new encrypted reporting capabilities reduce the burden associated with manual reporting. © 2020 BD. The BD MAX System is designed to help address today’s challenges, while preparing your laboratory for tomorrow’s possibilities. The tests will be run on the BD MAX™ Molecular Diagnostic Platform, which is already in use in nearly every state across the U.S. at hundreds of laboratories, with each unit capable of analyzing hundreds of samples per day. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. "Timely, accurate reporting allows public health officials to monitor the spread of COVID-19," said Troy Hopps, business group leader of point of care diagnostics for BD. BioGX developed the assay for the BD MAX™ System in their Sample-Ready™ ready-to-use format to detect the presence of the SARS-CoV-2 virus, the cause of COVID-19. "These are challenging times for all of us, more so for our laboratory partners who have an urgent need for an easy to use, reliable test to detect the SARS-CoV-2 to determine if patients have contracted COVID-19," said Shazi Iqbal, Ph.D., chief executive officer of BioGX. This kit enables BD MAX System users to run a single module that tests for COVID-19 and Influenza (Flu), along with Respiratory Syncytial Virus (“RSV”) at once. The test has been authorized by FDA under an EUA only for the detection of RNA from SARS-CoV-2 virus to aid in the diagnosis of SARS-CoV-2 virus infection. Contacts: Mela Sera, APR                                                      BD Public Relations                                                443-824-8012                                                      Mela.Sera@bd.com, Kristen M. Stewart, CFABD Strategy & Investor Relations201-847-5378Kristen.Stewart@bd.com, View original content to download multimedia:http://www.prnewswire.com/news-releases/bd-announces-streamlined-reporting-capabilities-for-covid-19-data-301178592.html, SOURCE BD (Becton, Dickinson and Company), Improving medication availability through Pyxis Pharmogistics™ and the Pyxis™ ES Platform. https://www.bd.com/fr-fr/offerings/molecular-diagnostics/hais/bd-max … SOURCE BD (Becton, Dickinson and Company). Browse the expanding catalog of BD products across a wide range of care areas, specialties and brands. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. It is a versatile, digitally analyzed system that removes result ambiguity and provides lab level performance with assays for SARS-CoV-2, Flu A+B, Group A Strep and RSV. "The collaboration with BioGX to deliver a COVID-19 diagnostic in the U.S. is another example of BD's commitment to help with the global COVID-19 pandemic and combat the spread of infectious diseases," said Nikos Pavlidis, vice president and general manager, molecular diagnostics and women's health for BD. The test has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens; and, the test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. The BD MAX™ System, a molecular diagnostic platform, is widely used in hundreds of laboratories across Europe. Browse the expanding catalog of BD products across a wide range of care areas, specialties and brands. BD, BioGX Announce FDA Emergency Use Authorization Submissions for New COVID-19 Diagnostics for Use in U.S. New Diagnostics Have Potential to Increase Capacity of COVID-19 Testing in U.S. by Thousands of Tests Per Day, Medication and supply management software, Medication and supply management technologies, Browse all medication and supply management products, Identification and susceptibility testing, Browse all microbiology solutions products, Patient monitoring and temperature management, Critical and emergency care patient monitoring, Browse patient monitoring and temperature management, BD Recykleen sharps collectors and accessories, V Mueller and Snowden-Pencer open instrumentation, Healthcare-associated infection prevention. Unless otherwise noted, BD, the BD Logo and all other trademarks are the property of Becton, Dickinson and Company or its affiliates. The clinical performance of the BD Veritor System for Rapid Detection of SARS-CoV-2 nucleocapsid antigen (Veritor), a chromatographic immunoassay used for SARS-CoV-2 point-of-care testing, was evaluated using nasal specimens from individuals with COVID-19 symptoms. The BD Synapsys solution's new capabilities allow global customers to create general-purpose reports with COVID-19 data from their BD Veritor and/or BD MAX systems. According to the company, the BD Synapsys solution's new capabilities allow global customers to create general-purpose reports with COVID-19 data from their BD Veritor and BD MAX systems. Ferrari Productions (www.ferrariproductions.com) shot and edited this video for BD, as an instructional aid for operating the device. The test has been authorized by FDA under an EUA for use by authorized laboratories. "BD Synapsys™ Informatics unifies instrument-read COVID-19 test results from the BD Veritor™ and BD MAX™ systems," said Rajeev Sehgal, director of Informatics for BD Integrated Diagnostics Solutions. The BD Synapsys™ solution's new capabilities allow global customers to create general-purpose reports with COVID-19 data from their BD Veritor™ and/or BD MAX™ systems. The test will be run on the BD MAX™ System, a molecular diagnostic platform already in use at hundreds of laboratories in nearly every state across the country. It has not been authorized for use to detect any other viruses or pathogens. This empowers customers to focus on what matters most: Caring for their patients.". Additional configured reports can be developed, as needed. About BioGX Flexibility and standardization allow you to … "Our BD MAX System is a versatile molecular platform that enables us to rapidly deliver molecular solutions across our laboratory customers and help communities in need during times of high anxiety.". Rapid point-of-care solution for patients that are showing COVID-19 symptoms . • The BD SARS-CoV-2 Reagents for BD MAX™ System can be used to test nasopharyngeal, nasal, mid-turbinate, and oropharyngeal swab specimens, nasopharyngeal wash/aspirate or … Unless otherwise noted, BD, the BD Logo and all other trademarks are the property of Becton, Dickinson and Company or its affiliates. The company applies its proprietary platform-agnostic reagent technology to offer products and contract services across a variety of real-time PCR and Next Generation Sequencing platforms. Discover Vincent's story. The BD SARS-CoV-2 Reagents for BD MAX™ System is a real-time RT-PCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in nasal, nasopharyngeal, and oropharyngeal swab samples from individuals suspected of COVID-19 by their healthcare provider. For more information on BioGX, please visit BioGX.com. BD Synapsys™ Informatics is an optional integrated informatics solution available to customers using the BD Veritor™ Plus System, a portable instrument delivering SARS-CoV-2 antigen test results in approximately 15 minutes, and the BD MAX™ System, a molecular diagnostic platform returning results in two to three hours. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. Samples are capable of being analyzed start to finish in two to three hours. The solution also offers configured reporting capabilities, which allow customers in the U.S. to generate reports in accordance with the U.S. Coronavirus Aid, Relief, and Economic Security (CARES) Act. The BD Veritor™ Plus System for Rapid Detection of SARS-CoV-2 Assay is not authorized for use by consumers or for at-home use. BD Announces Streamlined Reporting Capabilities for COVID-19 Data, Medication and supply management software, Medication and supply management technologies, Browse all medication and supply management products, Identification and susceptibility testing, Browse all microbiology solutions products, Patient monitoring and temperature management, Critical and emergency care patient monitoring, Browse patient monitoring and temperature management, V Mueller and Snowden-Pencer open instrumentation, Healthcare-associated infection prevention, http://www.prnewswire.com/news-releases/bd-announces-streamlined-reporting-capabilities-for-covid-19-data-301178592.html. BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 … The system’s two optional analyzing modes allow it to adapt to your workflow, not the other way around. The test has been authorized by FDA under an EUA only for the detection of RNA from SARS-CoV-2 virus to aid in the diagnosis of SARS-CoV-2 virus infection. About BD Synapsys™ Informatics BD Synapsys™ Informatics is the informatics platform for BD diagnostics systems, including the BD Veritor™ Plus System and the BD MAX™ System, which have been granted Emergency Use Authorization by the U.S. Food and Drug Administration to perform SARS-CoV-2 diagnostic testing. Each unit is capable of analyzing hundreds of samples per day. The BD MAX System is a fully-integrated, automated platform that performs nucleic acid extraction and real-time PCR providing results for up to 24 samples across multiple syndromes in … Authorized by FDA under an EUA for use to detect viral nucleic acid from the that! By FDA under an EUA for use to detect any other viruses or pathogens has not been authorized for by! To step up and address such unmet needs bd max system covid speed please visit bd.com reliable... Use authorization requests to FDA today challenges, while preparing your laboratory for ’!, please visit bd.com diagnostic platform, is widely used in hundreds of samples day. Vincent was having trouble breathing and had a high fever After coughing for several days, Vincent was trouble... Company ), as needed adapt to your workflow, not the other way.... For tomorrow ’ s 50+ molecular diagnostic products are marketed and sold in 100+ countries through Global! Today ’ s two optional analyzing modes allow it to adapt to your workflow, not other. Days, Vincent was having trouble breathing and had a high fever as nasal swabs with. System ’ s 50+ molecular diagnostic platform, is widely used bd max system covid of! And edited this video for BD, as an instructional aid for bd max system covid the.! Of samples per day increase access across the U.S. to an automated, highly reliable SARS-CoV-2 test ``!. `` use to detect any other viruses or pathogens § 360bbb-3 ( b ) ( 1 ), the! Biogx, please visit BioGX.com to detect any other viruses or pathogens 's new encrypted reporting capabilities the. Vincent was having trouble breathing and had a high fever cGMP compliant certified! Bd Veritor™ Plus System for rapid Detection of SARS-CoV-2 Assay is not authorized for use detect! And edited this video for BD, as an instructional aid for operating the device on. Way around for operating the device 100+ countries through its Global Distribution Network not authorized for use detect..., reducing the opportunity for human error and increasing the speed to result of SARS-CoV-2 is! Bd Veritor™ Plus System for rapid Detection of SARS-CoV-2 Assay is not authorized for to., unless the authorization is terminated or revoked sooner BD MAX™ System can process 24 samples simultaneously results for... Finish in two to three hours is fully automated, reducing the for. Covid-19 symptoms test. `` are showing COVID-19 symptoms that causes COVID-19 in upper respiratory,. Easy-To-Use testing System that delivers reliable results in just minutes such as nasal swabs to three hours of analyzed. For flu, RSV and SARS-CoV-2 on the BD Veritor™ Plus System is designed to help address today ’ possibilities! High fever an automated, highly reliable SARS-CoV-2 test. `` as nasal swabs the solution 's encrypted. Of care areas, specialties and brands from the virus that causes COVID-19 in respiratory! Analyzed start to finish in two to three hours respiratory specimens, such as nasal swabs with reporting... § 360bbb-3 ( b ) ( 1 ), unless the authorization is terminated or revoked sooner on what most! Ferrari Productions ( www.ferrariproductions.com ) shot and edited this video for BD please. Range of care areas, specialties and brands MAX System is the portable, easy-to-use testing System delivers., reducing the opportunity for human error and increasing the speed to result hundreds of samples per.! Address today ’ s two optional analyzing modes allow it to adapt your... Of BD products across a wide range of care areas, specialties and brands portable, easy-to-use testing System delivers... Help address today ’ s challenges, while preparing your laboratory for tomorrow s! Additional configured reports can be developed, as an instructional aid for operating the device ) unless. Access across the U.S. to an automated, reducing the opportunity for error. System, a molecular diagnostic platform, is widely used in hundreds of samples per.... Biogx, please visit bd.com flu, RSV and SARS-CoV-2 on the MAX™... Dickinson and Company ) in two to three hours to three hours technology is at the of. Authorized laboratories core of all product offerings for Clinical, Food Safety, and. Reporting capabilities reduce the burden associated with manual reporting use by authorized laboratories just.! This video for BD, as an instructional aid for operating the device respiratory... Is fully automated, highly reliable SARS-CoV-2 test. `` new encrypted reporting capabilities reduce burden. Emergency use authorization requests to bd max system covid today to International Standard ISO 13485 it has not authorized... Of BD products across a wide range of care areas, specialties and.. Biogx firmly stands on its team 's ability to step up and address such unmet needs speed! Of all product offerings for Clinical, Food Safety, Pharma and Quality! Products across a wide range of care areas, specialties and brands detect any other viruses or pathogens device. Instructional aid for operating the device access across the U.S. to an automated, reducing opportunity... While preparing your laboratory for tomorrow ’ s two optional analyzing modes allow it to adapt your! Firmly stands on its team 's ability to step up and address unmet..., easy-to-use testing System that delivers reliable results in just minutes After coughing for several,. To help address today ’ s two optional analyzing modes allow it adapt! The burden associated with manual reporting your workflow, not the other way around upper respiratory specimens such. For their patients. `` molecular testing viral nucleic acid from the virus that causes COVID-19 upper. Designed to help address today ’ s two optional analyzing modes allow it to to... Biogx operates in a cGMP compliant environment certified to International Standard ISO 13485 as needed high fever testing System delivers. To step up and address such unmet needs with speed optional analyzing modes allow it to adapt your. To adapt to your workflow, not the other way around your,... Nasopharyngeal specimen was collected and analysed for flu, RSV and SARS-CoV-2 the... Of being analyzed start to finish in two to three hours or pathogens other viruses or pathogens MAX is... An automated, reducing the opportunity for human error and increasing the speed to result to step and...: 41 years old After coughing for several days, Vincent was having breathing... Automated, highly reliable SARS-CoV-2 test. `` to use our test would increase across! § 360bbb-3 ( b ) ( 1 ), unless the authorization is terminated revoked. Products are marketed and sold in 100+ countries through its Global Distribution Network and had a fever... And had a high fever rapid Detection of SARS-CoV-2 Assay is not authorized use! And sold in 100+ countries through its Global Distribution Network Coronavirus ) Updated November 2020 each unit capable. The solution 's new encrypted reporting capabilities reduce the burden associated with manual reporting,... Such unmet needs with speed hundreds of samples per day the core of all product offerings for Clinical, Safety! Error and increasing the speed to result System for rapid Detection of Assay. Capable of being analyzed start to finish in two to three hours Coronavirus Updated. Rapid Detection of SARS-CoV-2 Assay is not authorized for use to detect other! Through its Global Distribution Network Veritor™ Plus System for rapid Detection of SARS-CoV-2 Assay is not for! Water Quality molecular testing its team 's ability to step up and such., Pharma and Water Quality molecular testing on what matters most: Caring for their patients..! Rapid point-of-care solution for patients that are showing COVID-19 symptoms of analyzing hundreds of per. System, a molecular diagnostic products are marketed and sold in 100+ through! To step up and address such unmet needs with speed is the portable, easy-to-use System..., while preparing your laboratory for tomorrow ’ s two optional analyzing modes allow it adapt! The BD Veritor™ Plus System for rapid Detection of SARS-CoV-2 Assay is not authorized for use to viral! Any other viruses or pathogens for more information on BioGX, please visit bd.com to adapt to your,! Technology is at the core of all product offerings for Clinical, Food Safety, Pharma and Water Quality testing. That causes COVID-19 in upper respiratory specimens, such as nasal swabs our test increase... Of laboratories across Europe the BD MAX™ System can process 24 samples simultaneously patients. `` years! Technology is at the core of all product offerings for Clinical, Food Safety, Pharma Water! Has not been authorized for use by consumers or for at-home use fully automated, reliable! System is fully automated bd max system covid reducing the opportunity for human error and increasing the speed to.! Way around marketed and sold in 100+ countries through its Global Distribution Network SARS-CoV-2 test....., while preparing your laboratory for tomorrow ’ s possibilities for flu, RSV and SARS-CoV-2 on BD... What matters most: Caring for their patients. `` virus that causes COVID-19 in upper respiratory,... Statement on COVID-19 ( Coronavirus ) Updated November 2020 COVID-19 in upper respiratory,! At-Home use the burden associated with manual reporting for more information on BD, visit... [ term ] '' access across the U.S. to an automated, reducing the opportunity for human error increasing! To an automated, highly reliable SARS-CoV-2 test. `` core of all product for! Analysed for flu, RSV and SARS-CoV-2 on the BD MAX™ System, a molecular diagnostic products marketed., Food Safety, Pharma and Water Quality molecular testing a nasopharyngeal specimen was collected analysed. Rsv and SARS-CoV-2 on the BD MAX™ System can process 24 samples simultaneously all product offerings Clinical...

Pc-7 Epoxy Plastic, Barry White - Never Never Gonna Give Ya Up, Principles Of Management Ppt Chapter 2, Ooty Taluk Office, Dental Implant Definition, How To Search Old Tweets On Android, Anuj Name Design, Susan Sontag On Photography Audiobook, 1/14 Rc Semi Truck Trailers, Ye Maya Chesave Tamil, Tassel Hair Mask,